Concepedia

Xiangrui Meng

XM

Statistics

Publications

5

Citations

98

H-Index

5

Active since

2023

Affiliations

Chengdu University of Traditional Chinese Medicine(Current)

Capital Medical University

Beijing Hospital of Traditional Chinese Medicine

Xiangrui Meng is an author at Chengdu University of Traditional Chinese Medicine specializing in pharmacology, lung histopathology, and pulmonary oxidative stress.

ORCID

Publications per year

2023–2025

5

Publications

5

Combined drug anti-deep vein thrombosis therapy based on platelet membrane biomimetic targeting nanotechnology

Hang Xiao, Xiangrui Meng, Songtao Li et al. · Biomaterials · 2024 · 31 citations

, , +17

Licochalcone B confers protective effects against LPS-Induced acute lung injury in cells and mice through the Keap1/Nrf2 pathway

Ju Huang, Yu Zhu, Songtao Li et al. · Redox Report · 2023 · 26 citations · Full text

, , +17

Evodiamine Inhibits Colorectal Cancer Growth via RTKs Mediated PI3K/AKT/p53 Signaling Pathway

Qiao Zheng, Shengnan Jing, Lin Hu et al. · Journal of Cancer · 2024 · 15 citations · Full text

, , +17

Gold-Crowned Bismuth-Based Nanocomposites for Sonodynamic, Photothermal, and Chemotherapeutic Cancer Therapy

Xiangrui Meng, Jingwen Liu, Qiao Zheng et al. · ACS Applied Materials & Interfaces · 2023 · 13 citations

, , +17

A metallic metabolic nano-regulator reprograms the PKM2/HIF-1α/DLAT axis to amplify tumor-specific cuproptosis

Hang Xiao, Xuelian Zhang, Songtao Li et al. · Biomaterials · 2025 · 13 citations

, , +15

1–5 of 5